Skip to content
  • Twitter
  • YouTube
ataxia-global-initiative

ataxia-global-initiative

worldwide platform for clinical research in ataxias

  • Home
  • About
    • SCA
    • ARCA
  • Governance
    • Charter
    • Membership
    • Partnership
    • Steering Committee
    • Ataxia Global Initiative Office
  • Working Groups
    • #1 Clinical outcome assessments & registries
    • #2 Molecular biomarkers & biosampling
    • #3 MRI biomarkers
    • #4 Digital-motor biomarkers
    • #5 Model systems & preclinical trials
    • #6 Next-generation genomics & platforms
    • #7 Policy and patient organization engagement
    • #8 Young investigator initiative
  • Projects
  • Resources
    • SARA Training Tool
    • Massachusetts General Hospital Ataxia Center Noon Conference
    • AGI YII webinar series
    • SCAsource
    • ERN-RND Ataxia Webinars
  • Young Investigator Initiative
    • Young Investigator Initiative (YII)
    • Training Curriculum
      • Ataxia scales training
      • AGI YII webinar series
      • Massachusetts General Hospital Ataxia Center Noon Conference
    • Members of the Young Investigator Initiative
    • Young Investigator Travel Award 2022
    • NAF Travel Award 2020
  • Events
    • Ataxia Global Conference 2022
      • Program
      • Young Investigator travel award
    • AGI’s Tools & Methods studio series
    • AGI symposium 2021
      • Program
    • SCA & ARCA Global Conference 2020
      • Programme & recorded sessions
      • Abstracts
      • Sponsors Online Booth
        • UCB
        • Cadent Therapeutics
        • uniQure
        • Biohaven pharmaceuticals
        • Roche
        • Ionis
        • Vico Therapeutics
        • Triplet Therapeutics
        • IXICO
    • Past events
  • News
    • News
    • Newsletters
  • Contact
  • Twitter
  • YouTube

25 September 2020 | International Ataxia Awareness Day (IAAD)

Author Comms ataxia globalPosted on September 25, 2020September 1, 2020Categories ATAXIA-Conferences, Conferences

Post navigation

Previous Previous post: European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative (ESMI) –lay summary of the results of this 4-year Consortium study
Next Next post: 19-21 October 2020 | SCA & ARCA Global Conference
Tweet Share

imprint, disclaimer and data-protection

  • Twitter
  • YouTube